Pharvaris Announces FDA Acceptance of New Drug Application for Deucrictibant IR for On ...

If approved, deucrictibant will be the first oral bradykinin B2 receptor antagonist to treat HAE attacksNDA includes positive data from ...

Patch AM: Could San Diego’s odor-control spray be weakening La Jolla’s kelp forests?

Coming up on the San Diego Patch calendar: Kids | Sewing: Junior Designer's Nature Makers, 7-12yrs ...